Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: clinical and experimental aspects - PubMed (original) (raw)
Review
Electrophysiologic effects of adenosine triphosphate and adenosine on the mammalian heart: clinical and experimental aspects
B Belhassen et al. J Am Coll Cardiol. 1984 Aug.
Free article
Abstract
Adenosine triphosphate (ATP) and adenosine have strong negative chronotropic and dromotropic effects on the mammalian heart. The sensitivity of the sinus node and the atrioventricular node to ATP and adenosine manifests pronounced variability among species. For more than three decades, ATP has been used routinely in Europe in the acute therapy of paroxysmal supraventricular tachycardia. Preliminary clinical trials with adenosine in the United States suggest that this compound may have a similar therapeutic value. The exact mechanisms of action of ATP and adenosine on the mammalian heart are still not fully known. However, the vast clinical experience indicates that ATP, and probably also adenosine, can be safely and repetitively used in the acute therapy of paroxysmal supraventricular tachycardia.
Similar articles
- On the mechanisms of cardiac electrophysiologic actions of adenosine and adenosine 5'-triphosphate.
Pelleg A, Miyagawa A, Michelson EL, Dreifus LS. Pelleg A, et al. Prog Clin Biol Res. 1988;275:225-37. Prog Clin Biol Res. 1988. PMID: 3051010 Review. - Therapeutic use of adenosine for terminating spontaneous paroxysmal supraventricular tachycardia.
Munoz A, Leenhardt A, Sassine A, Galley P, Puech P. Munoz A, et al. Eur Heart J. 1984 Sep;5(9):735-8. doi: 10.1093/oxfordjournals.eurheartj.a061734. Eur Heart J. 1984. PMID: 6499860 - Evidence for vagal involvement in the electrophysiologic actions of exogenous adenosine and adenosine triphosphate in the canine heart.
Pelleg A, Mitamura H, Michelson EL. Pelleg A, et al. J Auton Pharmacol. 1985 Sep;5(3):207-12. doi: 10.1111/j.1474-8673.1985.tb00121.x. J Auton Pharmacol. 1985. PMID: 4055818 - Evidence against prostaglandin mediation of the differential electrophysiologic effects of ATP versus adenosine in the canine heart.
Pelleg A, Mitamura H, Michelson EL, Dreifus LS. Pelleg A, et al. J Cardiovasc Pharmacol. 1986 May-Jun;8(3):534-8. doi: 10.1097/00005344-198605000-00015. J Cardiovasc Pharmacol. 1986. PMID: 2425169 - The mechanism of the negative chronotropic and dromotropic actions of adenosine 5'-triphosphate in the heart: an update.
Pelleg A, Belhassen B. Pelleg A, et al. J Cardiovasc Pharmacol. 2010 Jul;56(1):106-9. doi: 10.1097/FJC.0b013e3181e0f8b2. J Cardiovasc Pharmacol. 2010. PMID: 20386456 Review.
Cited by
- Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children.
Till J, Shinebourne EA, Rigby ML, Clarke B, Ward DE, Rowland E. Till J, et al. Br Heart J. 1989 Sep;62(3):204-11. doi: 10.1136/hrt.62.3.204. Br Heart J. 1989. PMID: 2789912 Free PMC article. - Cardiac purinergic signalling in health and disease.
Burnstock G, Pelleg A. Burnstock G, et al. Purinergic Signal. 2015 Mar;11(1):1-46. doi: 10.1007/s11302-014-9436-1. Epub 2014 Dec 20. Purinergic Signal. 2015. PMID: 25527177 Free PMC article. Review. - [Cardiac effects of adenosine. Mechanism of action, pathophysiologic and clinical significance].
Böhm M. Böhm M. Klin Wochenschr. 1987 Jun 1;65(11):487-99. doi: 10.1007/BF01721034. Klin Wochenschr. 1987. PMID: 2441109 German. - Adenosine: an old drug newly discovered.
Eltzschig HK. Eltzschig HK. Anesthesiology. 2009 Oct;111(4):904-15. doi: 10.1097/ALN.0b013e3181b060f2. Anesthesiology. 2009. PMID: 19741501 Free PMC article. Review. - Adenosine and hypoxia-inducible factor signaling in intestinal injury and recovery.
Colgan SP, Eltzschig HK. Colgan SP, et al. Annu Rev Physiol. 2012;74:153-75. doi: 10.1146/annurev-physiol-020911-153230. Epub 2011 Nov 19. Annu Rev Physiol. 2012. PMID: 21942704 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources